Oncocyte Prices $29.1 Million Equity Offering
Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch Strategic Partner Bio-Rad Invests, Boosts Support for Trial and Commercialization IRVINE, Calif., Feb. 10, 2025 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a pioneering...
Paradigm Oil and Gas Partners with Hallmark Venture Group to Drive Scalable Revenue Growth
Key Highlights: Strategic Partnership Announcement: Paradigm Oil and Gas, Inc. (OTC: PDGO) has engaged Hallmark Venture Group, Inc. (OTC: HLLK) to develop scalable revenue strategies and enhance digital operations. Revenue Growth & Digital Expansion: The...
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
BRIDGEWATER, NJ, February 10, 2025 - PRISM MediaWire - Catheter Precision Inc. (NYSE American: VTAK) (“Catheter Precision” or the “Company”), a U.S.-based medical device company focused on developing technologically advanced products for the cardiac electrophysiology...
Auddia Announces Continued Favorable 30-day Retention and the Launch of Commercial Subscriptions
faidr 30-day retention continues to build Upgraded subscription conversion optimization platform launched last week Subscription revenue guidance to be reported end of Q1 BOULDER, CO, February 10, 2024 - PRISM MediaWire - Auddia Inc. (NASDAQ: AUUD) (NASDAQ: AUUDW)...
Day Three of IBC Suriname 2025 Concludes with a Strong Focus on Finance, Investment, and Innovation
Key Points Finance, Investment, and Economic Growth Private-Sector Investment: Keynote by Ms. Elizabeth Robberechts emphasized the importance of leveraging financial instruments and fostering entrepreneurship to drive economic resilience. Sustainable Development:...
Day Two of IBC Suriname 2025 Focuses on Investment, Infrastructure, and Business Culture
Key Points: Investment & Economic Growth Investment Leadership: Keynote address emphasized integrated approaches to attract high-value investors and create sustainable business opportunities. Regulatory Improvements: Discussion on reducing bureaucratic barriers,...
AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios
Hauppauge, NY, February 6, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including...
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption
WEWAHITCHKA-PORT ST JOE, FL, February 6, 2025 - PRISM MediaWire - UAV Corp. (OTC: UMAV), a leader in advanced aerial surveillance and UAV technology, is rapidly expanding its market presence in response to the projected $58 billion growth in the global unmanned aerial...
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a randomized study designed to demonstrate Nociscan’s ability to improve surgical outcomes while reducing costs for chronic low back pain Nociscan aims to become the gold...
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
PITTSBURGH, February 6, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced that the U.S. Food and...